API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biopharmadive.com/news/takeda-ovid-soticlestat-rare-epilepsy-drug/595913/
https://www.biopharmadive.com/news/new-data-lead-ovid-takeda-to-push-seizure-drug-into-final-testing/584111/
https://www.takeda.com/newsroom/newsreleases/2020/phase-2-elektra-study-of-soticlestat-tak-935ov935-meets-primary-endpoint-reducing-seizure-frequency-in-children-with-dravet-syndrome-or-lennox-gastaut-syndrome/
https://www.biopharmadive.com/news/new-data-lead-ovid-takeda-to-push-seizure-drug-into-final-testing/584111/